DRUG FOR TREATMENT OF TINNITUS PATIENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170049717A1
SERIAL NO

15306258

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A drug for treatment of patients having tinnitus associated with sudden hearing loss, comprising neramexane or a pharmaceutically acceptable salt thereof, wherein the morbidity period of the patient having tinnitus associated with sudden hearing loss is 48 months or longer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KYORIN PHARMACEUTICAL CO LTDCHIYODA-KU

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ALTHAUS, Michael Frankfurt am Main, DE 16 4
BANKSTAHL, Ulli Kriftel, DE 1 0
CSIKOS, Janos Frankfurt am Main, DE 11 63
ELLERS-LENZ, Barbara Frankfurt am Main, DE 10 0
GORTELMEYER, Roman Frankfurt am Main, DE 2 0
HIRAHARA, Yoshifumi Chiyoda-ku, JP 2 0
KUROSE, Takafumi Chiyoda-ku, JP 9 34
NAGAI, Shinji Chiyoda-ku, JP 81 983
NIWAYAMA, Ikuyo Chiyoda-ku, JP 2 0
SHINOZAKI, Takehiro Chiyoda-ku, JP 4 25
TOMINAGA, Madoka Chiyoda-ku, JP 2 0
USHIWATA, Ai Chiyoda-ku, JP 2 0
WATANABE, Koichi Chiyoda-ku, JP 198 1137
YAMADA, Shinichi Chiyoda-ku, JP 177 2853

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation